|Medical Specialty||Reproductive Endocrinology
|IVF (In Vitro Fertilization)
Polycystic Ovary Syndrome (PCOS)
Treatment of infertility with in vitro fertilization (IVF), operative laparoscopy, and operative hysteroscopy
Robotic-assisted laparoscopic myomectomy
Polycystic ovary syndrome in infertility
|Insurance||Please contact Dr. McGovern's office to learn if he participates with your insurance plan.
|Board Certifications||American Board of Obstetrics and Gynecology, 1993
American Board of Obstetrics and Gynecology, Reproductive Endocrinology and Infertility Subspecialty, 1995
|Medical School||New York University School of Medicine, New York, NY, 1986
|Residency Training||Obstetrics and Gynecology, New York University‑Bellevue Medical Center, New York, NY, 1990
|Fellowship||Reproductive Endocrinology and Infertility, University of Dentistry and Medicine of New Jersey‑New Jersey Medical School, Newark, New Jersey, 1992
|Research / Advances||Regarding infertility treatment of women with polycystic ovary syndrome, Dr. McGovern authored the definitive randomized, controlled trial showing therapeutic superiority of clomiphene citrate (Clomid); published research showing that body weight is a predictor of success in treatment; and showed that induced or spontaneous bleeding before ovulation induction significantly lowers pregnancy rates.
Dr. McGovern has also published findings that traditional predictors of multiple pregnancy are not effective cancellation criteria for artificial insemination after fertility drugs; that antral (fluid-filled) follicle count is a significant predictor of live-birth pregnancy in IVF treatment cycles; and that singleton pregnancies after IVF treatment have a greater risk of preterm delivery than do those in the general population.
|From the doctor||Peter G. McGovern, MD, is the newly-installed chairman of the Department of Obstetrics and Gynecology at St. Luke’s and Roosevelt hospitals, and a physician member of Roosevelt’s Continuum Reproductive Center. In this position, he plans to continue his distinguished career in reproductive endocrinology and infertility. He joins the department from the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School, where he was Professor of Obstetrics, Gynecology, and Women’s Health; Director of the Division of Reproductive Endocrinology and Infertility since 1999; and REI Fellowship Program Director.
Among many notable accomplishments, Dr. McGovern was a steering-committee member of the NIH-funded National Cooperative Multicenter Reproductive Medicine Network from 2000-2007. While in this role, he served as the network’s principal investigator at UMDNJ, leading research on polycystic ovary syndrome (PCOS) and its interaction with infertility therapy. The randomized, controlled trial evaluated pregnancy rates in 626 women with PCOS who were treated with clomiphene citrate (Clomid), metformin (Glucophage), or the combination. Published in the New England Journal of Medicine, this groundbreaking research conclusively demonstrated that clomiphene citrate was the superior therapeutic option.
From 2001-2005, Dr. McGovern served as UMDNJ site co-investigator for the NIH-funded Women’s Health Initiative, which answered many questions about the role of hormone replacement therapy in postmenopausal women. In addition, he is an oral examiner for the American Board of Obstetrics and Gynecology in general obstetrics and gynecology and in the reproductive endocrinology and infertility subspecialty. He is a reviewer for the journals Fertility and Sterility, Obstetrics and Gynecology, and Journal of Clinical Endocrinology and Metabolism, and is an associate editor of Fertility and Sterility.
He serves on the Content Review Committee for the American Society for Reproductive Medicine (ASRM), and is the Clinical Director for the Society for Assisted Reproductive Technology (SART) which is responsible for oversight of all IVF centers in the USA.
|Address||425 West 59th Street, Suite 5A
New York NY 10019
Telephone: (212) 523-7751
1000 Tenth Avenue, Suite 10C01
New York NY 10019
Telephone: (212) 523-8234